Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
Trevi Therapeutics
TRVI
$1.75B
| $2.68M | ﹤0.01% |
489,300
+400,400
| +450% | +$2.49M |
2020 Q4
18 quarters
|
|
1927
FreightCar America
RAIL
$206M
| $2.67M | ﹤0.01% |
310,111
-143,506
| -32% | -$999K |
2023 Q4
6 quarters
|
|
1928
Capital Group Growth ETF
CGGR
$26.5B
| $2.66M | ﹤0.01% |
+65,500
| New | +$2.39M |
2025 Q2
0 quarters
|
|
1929
F&G Annuities & Life
FG
$2.5B
| $2.65M | ﹤0.01% |
83,000
+21,600
| +35% | +$717K |
2023 Q2
8 quarters
|
|
1930
Newell Brands
NWL
$2.38B
| $2.65M | ﹤0.01% |
491,527
-475,100
| -49% | -$2.52M |
2023 Q3
7 quarters
|
|
1931
Ranger Energy Services
RNGR
$363M
| $2.65M | ﹤0.01% |
222,090
+31,600
| +17% | +$379K |
2019 Q2
24 quarters
|
|
|
WSR
1932
DELISTED
Whitestone REIT
WSR
| $2.65M | ﹤0.01% |
212,184
+138,200
| +187% | +$1.76M |
2013 Q4
46 quarters
|
|
1933
Varex Imaging
VREX
$784M
| $2.65M | ﹤0.01% |
305,200
-3,500
| -1% | -$28.5K |
2021 Q3
15 quarters
|
|
1934
Transcat
TRNS
$814M
| $2.64M | ﹤0.01% |
30,700
+22,300
| +265% | +$1.82M |
2025 Q1
1 quarter
|
|
1935
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $2.64M | ﹤0.01% |
+53,300
| New | +$2.47M |
2025 Q2
0 quarters
|
|
1936
iShares Fallen Angels USD Bond ETF
FALN
$1.59B
| $2.63M | ﹤0.01% |
97,084
+78,884
| +433% | +$2.08M |
2024 Q3
3 quarters
|
|
1937
Grupo Aval
AVAL
$5.83B
| $2.63M | ﹤0.01% |
936,272
+43,000
| +5% | +$118K |
2015 Q2
40 quarters
|
|
1938
Northrim BanCorp
NRIM
$541M
| $2.63M | ﹤0.01% |
112,800
-4,400
| -4% | -$91.5K |
2013 Q2
48 quarters
|
|
1939
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.24B
| $2.63M | ﹤0.01% |
60,095
-98,105
| -62% | -$4.26M |
2025 Q1
1 quarter
|
|
1940
aTyr Pharma
ATYR
$19.7M
| $2.63M | ﹤0.01% |
518,355
+38,400
| +8% | +$151K |
2016 Q3
35 quarters
|
|
1941
Eastern Company
EML
$145M
| $2.63M | ﹤0.01% |
115,137
-2,000
| -2% | -$45K |
2013 Q2
48 quarters
|
|
1942
AMREP Corp
AXR
$109M
| $2.62M | ﹤0.01% |
125,400
-9,000
| -7% | -$193K |
2014 Q2
44 quarters
|
|
1943
Archrock
AROC
$5.38B
| $2.62M | ﹤0.01% |
105,400
-240,428
| -70% | -$5.89M |
2020 Q2
20 quarters
|
|
1944
Five Point Holdings
FPH
$315M
| $2.62M | ﹤0.01% |
475,600
+100,100
| +27% | +$536K |
2023 Q1
9 quarters
|
|
1945
Range Resources
RRC
$9.93B
| $2.61M | ﹤0.01% |
+64,291
| New | +$2.42M |
2025 Q2
0 quarters
|
|
1946
Marcus & Millichap
MMI
$1.05B
| $2.61M | ﹤0.01% |
85,000
+28,747
| +51% | +$872K |
2025 Q1
1 quarter
|
|
1947
Bank of Marin Bancorp
BMRC
$427M
| $2.61M | ﹤0.01% |
114,092
+11,324
| +11% | +$241K |
2014 Q1
45 quarters
|
|
1948
Standard Lithium
SLI
$353M
| $2.59M | ﹤0.01% |
1,323,474
+1,215,509
| +1,126% | +$1.91M |
2024 Q4
2 quarters
|
|
1949
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $2.59M | ﹤0.01% |
60,100
-194,000
| -76% | -$8.21M |
2023 Q2
8 quarters
|
|
1950
Northwest Bancshares
NWBI
$2.15B
| $2.59M | ﹤0.01% |
202,699
-9,015
| -4% | -$109K |
2024 Q3
3 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.